Adam Milton-Barker is the founder & Managing Director of Peter Moss Leukaemia MedTech Reserch, and Peter's eldest grandson.
Adam is a professional freelancer with experience in web development, business administration systems, social media marketing, Facebook applications, the Internet of Things, Artificial Intelligence, Virtual & Mixed Reality & Blockchain technologies.
Adam began his journey utilizing Artificial Intelligence for cancer detection in 2018 with Breast Cancer AI before creating the Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project when Peter was diagnosed with AML in late 2018.